Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Molgaard-Nielsen, 2013 |
Denmark 1996 - 2011 |
All liveborn infants who were born in Denmark during the study period. | Women who fill prescriptions for oral ketoconazole agents during the first trimester. |
unexposed (general population or NOS)
Women who did not fill prescriptions for oral azole antifungal agents during the first trimester. |
72 / 968236 | Oral exposure. |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|---|---|---|---|---|
Carter, 2008 |
USA 1997 - 2003 |
Cases with selected birth defects (included live births, stillbirths 20 weeks or longer or greater than 500 g, or elective terminations). | Live births without birth defects that were randomly selected from birth certificates or birth hospitals in the geographic regions monitored by the state surveillance systems. | 12274 / 4774 | |
Kazy, 2005 |
Hungary 1980 - 1996 |
Cases with isolated and multiple congenital anomalies selected from the Hungarian Congenital Abnormality Registry. | Newborn infants without congenital abnormality. | 22843 / 38151 | Oral ketoconazole exposure. |